Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K- ras

Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth... ORIGINAL ARTICLE Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status Takamitsu Onitsuka, MD,* Hidetaka Uramoto, PhD, MD,* Kenji Ono, PhD, MD,* Mitsuhiro Takenoyama, PhD, MD,* Takeshi Hanagiri, PhD, MD,* Tsunehiro Oyama, PhD, MD,† Hiroto Izumi, PhD, MD,‡ Kimitoshi Kohno, PhD, MD,‡ and Kosei Yasumoto, PhD, MD* The wild type of K-ras, negative p-MET 1234/1235, and positive Background: The mutation and amplification of oncogenic genes expression of HGF may be a useful marker for predicting poor are associated with carcinogenesis and tumor growth. The purpose prognosis of patients who underwent surgical resection of lung of this study was to clarify the role of the epidermal growth factor adenocarcinoma. receptor (EGFR), K-ras, MET, and hepatocyte growth factor (HGF) Key Words: EGFR, K-ras, MET, HGF, Lung cancer, status in lung adenocarcinoma. Adenocarcinoma. Methods: Tumor specimens were collected from 183 patients who underwent a complete resection for adenocarcinoma of the lung (J Thorac Oncol. 2010;5: 591–596) from 2003 to 2007 in our department. The genetic status of the EGFR and K-ras genes were investigated by polymerase chain reaction (PCR)-based analyses. Immunohistochemistry and real time ung cancer is the leading cause http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K- ras

Journal of Thoracic Oncology , Volume 5 (5) – May 1, 2010

Loading next page...
 
/lp/wolters-kluwer-health/comprehensive-molecular-analyses-of-lung-adenocarcinoma-with-regard-to-tq7e4XeYjg

References (41)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181d0a4db
pmid
20150826
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status Takamitsu Onitsuka, MD,* Hidetaka Uramoto, PhD, MD,* Kenji Ono, PhD, MD,* Mitsuhiro Takenoyama, PhD, MD,* Takeshi Hanagiri, PhD, MD,* Tsunehiro Oyama, PhD, MD,† Hiroto Izumi, PhD, MD,‡ Kimitoshi Kohno, PhD, MD,‡ and Kosei Yasumoto, PhD, MD* The wild type of K-ras, negative p-MET 1234/1235, and positive Background: The mutation and amplification of oncogenic genes expression of HGF may be a useful marker for predicting poor are associated with carcinogenesis and tumor growth. The purpose prognosis of patients who underwent surgical resection of lung of this study was to clarify the role of the epidermal growth factor adenocarcinoma. receptor (EGFR), K-ras, MET, and hepatocyte growth factor (HGF) Key Words: EGFR, K-ras, MET, HGF, Lung cancer, status in lung adenocarcinoma. Adenocarcinoma. Methods: Tumor specimens were collected from 183 patients who underwent a complete resection for adenocarcinoma of the lung (J Thorac Oncol. 2010;5: 591–596) from 2003 to 2007 in our department. The genetic status of the EGFR and K-ras genes were investigated by polymerase chain reaction (PCR)-based analyses. Immunohistochemistry and real time ung cancer is the leading cause

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: May 1, 2010

There are no references for this article.